Literature DB >> 1371391

Regional studies of serotonin and dopamine metabolism and quantification of serotonin uptake sites in human cerebral cortex.

B Parsons1, A Roxas, Y Y Huang, A Dwork, M Stanley.   

Abstract

An increasing number of studies have indicated that neuronal metabolism of serotonin (5-HT) and other monoamines may be altered in patients with affective disorders and in completed suicides. However, studies have yielded discordant results. The purpose of this study was to determine the regional variation of 5-hydroxyindolacetic acid (5-HIAA), homovanillic acid (HVA), (5-HT) and 5-HT uptake sites within the human cerebral cortex. Our sample consisted of 19 patients who died suddenly and accidently. Cortical concentrations of 5-HIAA, HVA and 5-HT were measured in six regions using an HPLC. 5-HT uptake sites in cortex were examined using [3H]-Paroxetine. 5-HT values within each brain were fairly constant in cortical regions studied except for the posterior parietal areas. By contrast, 5-HIAA values showed a trend towards a rostro-caudal increase, with peak values seen at sections corresponding to the post-central gyrus and the occipital pole. Using the ratio of 5-HIAA/5-HT as a crude index of 5-HT turnover, there was a progressive rostro-caudal increase of values which achieved statistical significance: the posterior superior parietal area and the occipital pole displayed a greater ratio than the other four cortical regions. HVA values were highest in the pre-central region and decreased both rostrally and caudally. 5-HIAA and HVA values were correlated positively in 5 of 6 cortical areas, while 5-HIAA and 5-HT were correlated in areas 4 and 5. Results obtaining using [3H]-Paroxetine suggest that 5-HT uptake sites in the human cortex are distributed rather uniformally and are not correlated with 5-HT levels.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371391     DOI: 10.1007/bf01253111

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  34 in total

1.  Regional serotonin levels in brain: a comparison of depressive suicides and alcoholic suicides with controls.

Authors:  E Cochran; E Robins; S Grote
Journal:  Biol Psychiatry       Date:  1976-06       Impact factor: 13.382

2.  The level and diurnal rhythm of serum serotonin in manic-depressive patients.

Authors:  K Sarai; M Kayano
Journal:  Folia Psychiatr Neurol Jpn       Date:  1968

3.  Pitfalls in membrane binding sites studies in post-mortem human brain.

Authors:  R Cash; R Raisman; P Cervera; F Javoy-Agid; Y Agid
Journal:  J Recept Res       Date:  1987

4.  Binding of a specific 5-HT uptake inhibitor, [3H]norzimelidine, to rat brain homogenates.

Authors:  H Hall; S Ross; S O Ogren; L Gawell
Journal:  Eur J Pharmacol       Date:  1982-05-21       Impact factor: 4.432

5.  Regional distribution of monoamines and their metabolites in the human brain.

Authors:  A V Mackay; C M Yates; A Wright; P Hamilton; P Davies
Journal:  J Neurochem       Date:  1978-04       Impact factor: 5.372

6.  Dopamine metabolites in human brain.

Authors:  S Wilk; M Stanley
Journal:  Psychopharmacology (Berl)       Date:  1978-04-14       Impact factor: 4.530

7.  Determination of monoamine and monoamine metabolites in the human brain: post mortem studies in a group of suicides and in a control group.

Authors:  J Beskow; C G Gottfries; B E Roos; B Winblad
Journal:  Acta Psychiatr Scand       Date:  1976-01       Impact factor: 6.392

8.  5-Hydroxytryptamine-sensitive [3H]imipramine binding of protein nature in the human brain. I. Characteristics.

Authors:  I T Bäckström; J O Marcusson
Journal:  Brain Res       Date:  1987-11-03       Impact factor: 3.252

9.  Involvement of hippocampal serotonergic activity in age-related changes in exploratory behavior.

Authors:  M J Brennan; A Dallob; E Friedman
Journal:  Neurobiol Aging       Date:  1981       Impact factor: 4.673

10.  Mesolimbic dopamine lesions produce an augmented behavioral response to enkephalin.

Authors:  P W Kalivas; M Bronson
Journal:  Neuropharmacology       Date:  1985-10       Impact factor: 5.250

View more
  1 in total

1.  Brain monoaminergic and neuropeptidergic variations in human aging.

Authors:  B Arranz; K Blennow; R Ekman; A Eriksson; J E Månsson; J Marcusson
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.